Gapping up
In reaction to earnings/guidance:
- LE +6.2%, CRWD +2.9%, FF +2.7%, HIL +2%, LEN +0.7%
Other news:
- IMTX +23.8% (presents data update on dose escalation from ongoing ACTengine cell therapy programs)
- TNXP +8.7% (preliminary results following vaccination of non-human primates with TNX-1800)
- CELC +5.7% (NVS, PBYI, CELC and MD Anderson to collaborate to study new drug regimen)
- PBYI +4.3% (NVS, PBYI, CELC and MD Anderson to collaborate to study new drug regimen)
- GLG +2.6% (signs LOI with Chenzhou Dingmei Silver to acquire ownership of a molybdenum copper ore in Kazakhstan)
- COHR +2.5% (Coherent confirms new acquisition proposal from Lumentum (LITE))
- CRNT +1.8% (announces a Tier 1 Operator in the Pacific Rim has placed a significant follow-on frame agreement for its flexible wireless hauling solutions)
- PDCO +1.6% (approves new $500 mln share repurchase authorization)
- QRTEA +1% (QRTEA discloses 25.5% stake in SCOR)
- BALY +0.9% (receives temporary sports wagering permit in Virginia)
- IIVI +0.6% (Coherent confirms new acquisition proposal from Lumentum (LITE))
Analyst comments:
- FNKO +2.1% (upgraded to Market Perform from Underperform at BMO Capital Markets)
- AA +1.1% (upgraded to Buy from Hold at Deutsche Bank)
- MCD +0.9% (upgraded to Buy from Hold at Deutsche Bank)